218 related articles for article (PubMed ID: 8981930)
1. Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.
Wing MG; Moreau T; Greenwood J; Smith RM; Hale G; Isaacs J; Waldmann H; Lachmann PJ; Compston A
J Clin Invest; 1996 Dec; 98(12):2819-26. PubMed ID: 8981930
[TBL] [Abstract][Full Text] [Related]
2. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
[TBL] [Abstract][Full Text] [Related]
3. Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.
Stauch D; Dernier A; Sarmiento Marchese E; Kunert K; Volk HD; Pratschke J; Kotsch K
PLoS One; 2009; 4(3):e4709. PubMed ID: 19266059
[TBL] [Abstract][Full Text] [Related]
4. Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.
Wing MG; Waldmann H; Isaacs J; Compston DA; Hale G
Ther Immunol; 1995 Aug; 2(4):183-90. PubMed ID: 9358610
[TBL] [Abstract][Full Text] [Related]
5. FcγRIIIa-dependent IFN-γ release in whole blood assay is predictive of therapeutic IgG1 antibodies safety.
Alakhras NS; Qiu J; Rocha GV; Witcher DR; Koester A; You J; Schaer DA; Holmgaard RB; Driscoll K; Willy JA; Malherbe LP
MAbs; 2018; 10(6):913-921. PubMed ID: 29953319
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells.
Nagler A; Condiotti R; Lubina A; Deutsch VR
Bone Marrow Transplant; 1997 Oct; 20(7):525-31. PubMed ID: 9337053
[TBL] [Abstract][Full Text] [Related]
7. Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells.
Jewett A; Cacalano NA; Head C; Teruel A
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1994-2003. PubMed ID: 16609008
[TBL] [Abstract][Full Text] [Related]
8. Activation of cloned human natural killer cells via Fc gamma RIII.
Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
10. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ
MAbs; 2015; 7(3):494-504. PubMed ID: 25933349
[TBL] [Abstract][Full Text] [Related]
11. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages.
Kramer PR; Kramer SF; Guan G
Arthritis Rheum; 2004 Jun; 50(6):1967-75. PubMed ID: 15188374
[TBL] [Abstract][Full Text] [Related]
13. Signaling through the LFA-1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells.
Melero I; Balboa MA; Alonso JL; Yagüe E; Pivel JP; Sanchez-Madrid F; López-Botet M
Eur J Immunol; 1993 Aug; 23(8):1859-65. PubMed ID: 8344347
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
Borrego F; Lopez-Beltran A; Peña J; Solana R
Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
[TBL] [Abstract][Full Text] [Related]
15. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
Heiskala M; Ståhls A; Seppälä I; Timonen T
Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
[TBL] [Abstract][Full Text] [Related]
16. Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.
Hussain K; Hargreaves CE; Rowley TF; Sopp JM; Latham KV; Bhatta P; Sherington J; Cutler RM; Humphreys DP; Glennie MJ; Strefford JC; Cragg MS
Front Immunol; 2019; 10():390. PubMed ID: 30899264
[TBL] [Abstract][Full Text] [Related]
17. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
[TBL] [Abstract][Full Text] [Related]
18. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Hadley AG; Zupanska B; Kumpel BM; Leader KA
Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
[TBL] [Abstract][Full Text] [Related]
19. Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.
Condiotti R; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):713-20. PubMed ID: 8899185
[TBL] [Abstract][Full Text] [Related]
20. Fc gamma-receptor III (CD 16) is involved in NK-B cell interaction.
Lenz P; Gessner JE; Sautes C; Schmidt RE
Immunobiology; 1996; 196(4):387-98. PubMed ID: 9061379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
